UNSPSC 51281810: Valrubicin

This classification denotes an anthracycline antibiotic with the molecular formula C34H36F3NO13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2C6NUM6878, chemically known as pentanoic acid, 2-((2s,4s)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-((2,3,6-trideoxy-3-((trifluoroacetylamino)-, alpha-l-lysohexopyranoxyl)oxy)-2-naphthacenyl)-2-oxoethyl ester but generally known as valrubicin, which bears US NIH Compound Identifier 41744.

UNSPSC 51281810 Valrubicin, a Commodity code, does not align with actual recent state and local procurement activity under this code. The two opportunities posted in the source are a completed Illinois Department of Public Health pharmaceutical warehouse piggyback contract for Doxycycline Hyclate and Ciprofloxacin Hydrochloride (neither valrubicin), and a Seminole County, Florida IFB for Naloxone and Safe Drug Deactivation Systems. Neither procurement involves valrubicin, an injectable chemotherapy agent used in bladder cancer treatment. The code shows no recent solicitation activity that matches its nominal scope.

The geographic and issuing-body signals are therefore limited. The two opportunities represent a state health department (Illinois) and a county government (Florida) in different commodity areas. No issuing body appears as a repeat buyer under this code in the recent record, and no pattern of valrubicin procurement activity supports a forward-looking business case for pursuit under this code classification.